Smaio S.A (ALSMA) | Financial Analysis & Statements
Smaio S.A. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Income Metrics
Balance Sheet Metrics
Total Assets
11.8M
Total Liabilities
4.9M
Shareholders Equity
6.8M
Debt to Equity
0.72
Cash Flow Metrics
Revenue & Profitability Trend
Annual Income Flow
2024
Smaio S.A Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 5.7M | 7.6M | 2.4M | 2.1M | 1.2M |
| Cost of Goods Sold | 2.4M | 2.4M | 2.0M | 1.5M | 1.6M |
| Gross Profit | 3.3M | 5.2M | 443.6K | 595.8K | -417.3K |
| Gross Margin % | 58.4% | 68.4% | 18.2% | 28.0% | -33.9% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | - | - | - | - | - |
| Other Operating Expenses | 249.6K | 92.2K | 123.9K | 36.2K | -84.8K |
| Total Operating Expenses | 249.6K | 92.2K | 123.9K | 36.2K | -84.8K |
| Operating Income | -1.5M | 736.9K | -4.0M | -3.4M | -2.5M |
| Operating Margin % | -26.3% | 9.7% | -163.6% | -157.8% | -201.7% |
| Non-Operating Items | |||||
| Interest Income | 139.1K | 128.6K | 6.6K | 0 | 0 |
| Interest Expense | 44.3K | 35.6K | 3.5K | 28.8K | 16.1K |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | -1.4M | 651.9K | 2.6M | -3.4M | -2.5M |
| Income Tax | -446.4K | -406.6K | -220.6K | -308.5K | -277.6K |
| Effective Tax Rate % | 0.0% | -62.4% | -8.4% | 0.0% | 0.0% |
| Net Income | -933.4K | 1.1M | 2.8M | -3.1M | -2.2M |
| Net Margin % | -16.3% | 13.9% | 116.5% | -145.4% | -180.5% |
| Key Metrics | |||||
| EBITDA | -28.3K | 2.0M | -2.5M | -2.3M | -1.9M |
| EPS (Basic) | €-0.18 | €0.21 | €0.55 | €-0.59 | €-0.43 |
| EPS (Diluted) | €-0.18 | €0.21 | €0.55 | €-0.59 | €-0.43 |
| Basic Shares Outstanding | 5216257 | 5215414 | 5210016 | 5228651 | 5228651 |
| Diluted Shares Outstanding | 5216257 | 5215414 | 5210016 | 5228651 | 5228651 |
Income Statement Trend
Smaio S.A Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 3.2M | 6.9M | 5.7M | 573.8K | 240.1K |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 1.7M | 602.5K | 447.1K | 382.5K | 222.7K |
| Inventory | 1.3M | 1.2M | 1.4M | 1.6M | 1.8M |
| Other Current Assets | -2 | -2 | - | - | - |
| Total Current Assets | 8.3M | 10.3M | 8.5M | 4.0M | 3.0M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 2.1M | 1.8M | 1.5M | 1.4M | 886.1K |
| Goodwill | 2.3M | 2.3M | 2.3M | 2.5M | 2.5M |
| Intangible Assets | 2.3M | 2.3M | 2.3M | 2.5M | 2.5M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | - | 1 | -1 | - | - |
| Total Non-Current Assets | 3.5M | 3.5M | 3.5M | 4.3M | 3.5M |
| Total Assets | 11.8M | 13.8M | 11.9M | 8.3M | 6.5M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 1.6M | 693.5K | 762.1K | 559.5K | 423.4K |
| Short-term Debt | 463.5K | 379.3K | 374.6K | 7.8M | 6.1M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | 631.9K | 455.9K | 334.0K |
| Total Current Liabilities | 3.0M | 1.4M | 1.9M | 8.9M | 6.9M |
| Non-Current Liabilities | |||||
| Long-term Debt | 1.8M | 3.1M | 0 | 0 | - |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | - | -2 | - | - | - |
| Total Non-Current Liabilities | 1.9M | 3.1M | 351.3K | 0 | 0 |
| Total Liabilities | 4.9M | 4.5M | 2.2M | 8.9M | 6.9M |
| Equity | |||||
| Common Stock | 993.4K | 993.4K | 993.4K | 686.7K | 3.0M |
| Retained Earnings | -2.3M | -446.2K | -251.1K | -3.1M | -3.5M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 6.8M | 9.3M | 9.7M | -618.9K | -437.9K |
| Key Metrics | |||||
| Total Debt | 2.3M | 3.4M | 374.6K | 7.8M | 6.1M |
| Working Capital | 5.2M | 8.9M | 6.6M | -4.9M | -3.9M |
Balance Sheet Composition
Smaio S.A Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -2.3M | -446.2K | 2.8M | -3.1M | -2.2M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -1.1M | -3.1M | 642.3K | -650.6K | -1.9M |
| Operating Cash Flow | -3.4M | -3.6M | 4.1M | -3.7M | -4.1M |
| Investing Activities | |||||
| Capital Expenditures | -1.6M | -1.5M | -830.3K | -1.3M | -1.7M |
| Acquisitions | 0 | 0 | - | - | - |
| Investment Purchases | 0 | 0 | - | - | - |
| Investment Sales | 34.3K | 0 | - | - | - |
| Investing Cash Flow | -1.4M | -1.5M | -919.3K | -1.3M | -1.7M |
| Financing Activities | |||||
| Share Repurchases | -121.5K | -52.7K | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 42.2K | 2.5M | 0 | 4.1M | 4.6M |
| Debt Repayment | -794.7K | -131.1K | -7.4M | -2.4M | 0 |
| Financing Cash Flow | -839.6K | 2.4M | 81.8K | 4.1M | 4.7M |
| Free Cash Flow | -3.0M | -1.2M | 5.1M | -3.8M | -5.0M |
| Net Change in Cash | -5.7M | -2.7M | 3.3M | -897.6K | -1.1M |
Cash Flow Trend
Smaio S.A Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
16.30
Forward P/E
33.04
Price to Book
5.78
Price to Sales
5.65
PEG Ratio
33.04
Profitability Ratios
Profit Margin
-22.35%
Operating Margin
-18.86%
Return on Equity
-24.00%
Return on Assets
-11.52%
Financial Health
Current Ratio
3.46
Debt to Equity
41.76
Beta
0.53
Per Share Data
EPS (TTM)
€-0.39
Book Value per Share
€1.31
Revenue per Share
€1.55
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| ALSMA | 47.0M | 16.30 | 5.78 | -24.00% | -22.35% | 41.76 |
| Cegedim S.A | 188.1M | 92.86 | 0.54 | -4.95% | -2.25% | 115.34 |
| Abl Diagnostics | 44.4M | 92.00 | 5.94 | 6.73% | 7.44% | 38.66 |
| Intrasense S.A | 11.8M | - | - | -314.39% | -244.82% | -0.21 |
| Media Lab S.p.A | 8.1M | 18.89 | 5.88 | 35.13% | 23.18% | - |
Financial data is updated regularly. All figures are in the company's reporting currency.